Argenx
ARGX
#472
Rank
A$74.24 B
Marketcap
A$1,181
Share price
0.78%
Change (1 day)
-4.08%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): A$23.66

According to Argenx 's latest financial reports the company's current EPS (TTM) is A$22.63. In 2025 the company made an earnings per share (EPS) of A$30.17 an increase over its 2024 EPS that were of A$19.92.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$23.66-21.56%
2025A$30.1751.44%
2024A$19.92-369.77%
2023A-$7.38-60.46%
2022A-$18.6863.33%
2021A-$11.43-40.37%
2020A-$19.18183.47%
2019A-$6.76123.09%
2018A-$3.0354.93%
2017A-$1.9614.07%
2016A-$1.7213.05%
2015A-$1.52-36.34%
2014A-$2.38209.04%
2013A-$0.77-33.99%
2012A-$1.17185.59%
2011A-$0.41